Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

25-Apr-16 - 23-Apr-17
Buy Ratio:41%

Up

# Net Buyers:134
# Net Sellers:192

Previous 52 Weeks

27-Apr-15 - 24-Apr-16
Buy Ratio:38%
# Net Buyers:132
# Net Sellers:218
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Pharmacyclics Inc--$3.71B  
Valeant Pharmaceuticals International, Inc.($212.40M)$841.75M  
China Biologic Products, Inc.($643.43M)$831.88M  
Colucid Pharmaceuticals, Inc.$712.95M$714.21M  
Juno Therapeutics, Inc.($18.17M)$422.12M  
New Net Buyers
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.$712.95M$714.21M  
Tobira Therapeutics, Inc.$67.65M$71.15M  
Abbott Laboratories$24.79M$58.42M  
Novelion Therapeutics Inc.$2.21M$58.18M  
Ocular Therapeutix, Inc$422.60K$57.74M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.84B)($1.83B)  
Zoetis Inc.($792.61M)($789.46M)  
Seattle Genetics Inc /wa$112.59M($405.09M)  
Incyte Corp($47.63M)($223.15M)  
Catalent, Inc.($629.96M)($216.91M)  
New Net Sellers
CompanyNet Buy AmountChange
Incyte Corp($47.63M)($223.15M)  
Global Blood Therapeutics, Inc.($93.75M)($93.80M)  
Biogen Inc.($2.02M)($78.13M)  
Esperion Therapeutics, Inc.($49.11M)($49.35M)  
Ardelyx, Inc.($481.62K)($29.85M)